Procalcitonin: New insights on regulation and origin

Critical Care Medicine

Volumn 28, Issue 2, 2000, Pages 586-588

  Braithwaite, Susan S ^a  

^a Mayo Health System   (United States)

Author keywords

Acute phase proteins; Acute phase reaction; Calcitonin; Cytokines; Osteoclast; Protein precursors; Receptors

Indexed keywords

ACUTE PHASE PROTEIN; CALCITONIN; INTERLEUKIN 6; PROCALCITONIN; TUMOR NECROSIS FACTOR ALPHA;

CYTOKINE RELEASE; EDITORIAL; HORMONE SYNTHESIS; HUMAN; INFLAMMATION; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SECRETION; SEPSIS;

EID: 0034005691     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200002000-00058     Document Type: Editorial

References (21)

1. 1. Lee SK, Goldring SR, Lorenza JA: Expression of the calcitonin receptor in bone marrow cell cultures and in bone: A specific marker of the differentiated osteoclast that is regulated by calcitonin. Endocrinology 1995; 136:4572-4581
2. 2. Gorn AH, Lin HY, Yamin M, et al: Cloning, characterization, and expression of a human calcitonin receptor from an ovarian carcinoma cell line. J Clin Invest 1992; 90: 1726-1735
3. 3. Nijsten MWN, Olinga P, Hauw The T, et al: Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med 2000; 28:458-461
4. 4. Ghillani P, Motte P, Troalen F, et al: Identification and measurement of calcitonin precursor in serum of patients with malignant diseases. Cancer Res 1989; 49:6845-6851
5. 5. Whang KT, Steinwald PM, White JC, et al: Serum calcitonin precursors in sepsis and systemic inflammation. J Clin Endocrinol Metab 1998; 83:3296-3301
6. 6. Becker KL, Bivins LE, Radfar RH, et al: Study of calcitonin heterogeneity using a radioreceptor assay. Horm Metab Res 1978; 10: 457-458
7. 7. Zaidi M, Moonga BS, Bevis PJ, et al: Expression and function of the calcitonin gene products. Vitam Horm 1991; 46:87-164
8. 8. Dandona P, Nix D, Wilson MR, et al: Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994; 79:1605-1608
9. 9. Assicot M, Gendrel D, Carsin H, et al: High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 341:515-518
10. 10. Monneret G, Labaune JM, Isaac C, et al: Procalcitonin, and C-reactive protein levels in neonatal infections. Acta Paediatr 1997; 86: 209-212
11. 11. Lapillone A, Basson E, Monneret G, et al: Lack of specificity of procalcitonin for sepsis diagnosis in premature infants. Lancet 1998; 351:1211-1212
12. 12. Sachse C, Dressler F, Henkel E: Increased serum procalcitonin in newborn infants without infection. Clin Chem 1998; 44: 1343-1344
13. 13. Meisner M, Tschaikowsky K, Hutzler A, et al: Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med 1998; 24:680-684
14. 14. Moosig F, Reinhold-Keller E, Csernok E, et al: Limitations on the usefulness of procalcitonin as a marker of infection in patients with systemic autoimmune disease: Comment on the article by Eberhard et al. Arthritis Rheum 1998; 41:566-567
15. 15. Mimoz O, Benoist JF, Edouard AR, et al: Procalcitonin, and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome. Intensive Care Med 1998; 24:185-188
16. 16. Kunz D, Pross M, König W, et al: Diagnostic relevance of procalcitonin, IL-6, and cellular immune status in the early phase after liver transplantation. Transplant Proc 1998; 30: 2398-2399
17. 17. Oberhoffer M, Stonans I, Russwurm S, et al: Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro. J Lab Clin Med 1999; 134:49-55
18. 18. Monneret G, Laroche B, Bienvenu J: Procalcitonin is not produced by circulating blood cells. Infection 1999; 27:34-35
19. 19. Nylen ES, Whang KT, Snider RH, et al: Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med 1998; 26:1001-1006
20. 20. Suda T, Takahashi N, Udagawa N, et al: Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 1999; 20:345-357
21. 21. Roodman GD: Advances in bone biology: The osteoclast. Endocr Rev 1996: 17:308-332